Do ginger-derived nanoparticles represent an attractive treatment strategy for inflammatory bowel diseases?
Institute for Biomedical Sciences, Center for Diagnostics & Therapeutics, Georgia State University, Atlanta, GA, 30302 USA.
Mingzhen
M
Zhang
Food Science & Human Nutrition Department, University of Florida, Gainesville, FL, 32611 USA.
James F
JF
Collins
Institute for Biomedical Sciences, Center for Diagnostics & Therapeutics, Georgia State University, Atlanta, GA, 30302 USA.|Atlanta Veterans Affairs Medical Center, Decatur, GA, 30033 USA.
Didier
D
Merlin
D020939:Zingiber officinale; D015212:Inflammatory Bowel Diseases; D053758:Nanoparticles
colitis-associated cancer; ginger-derived nanoparticles; inflammatory bowel disease; natural drug delivery system; therapy